0,927  0,004  Antidepressant
0,919  0,004  Mood disorders treatment
0,883  0,004  CYP2D6 substrate
0,881  0,004  CYP1A2 substrate
0,808  0,004  CYP2C19 substrate
0,804  0,007  CYP2C9 substrate
0,798  0,005  Analgesic, non-opioid
0,797  0,004  Antineurogenic pain
0,790  0,006  Analgesic
0,776  0,003  Muscle relaxant
0,749  0,004  Psychostimulant
0,729  0,016  CYP3A4 substrate
0,715  0,004  Sedative
0,687  0,002  CNS active muscle relaxant
0,680  0,003  Antiparkinsonian, rigidity relieving
0,683  0,007  Spasmolytic
0,647  0,003  5 Hydroxytryptamine 1F antagonist
0,648  0,011  Anxiolytic
0,641  0,005  CYP2D6 inhibitor
0,639  0,011  5 Hydroxytryptamine release stimulant
0,642  0,021  Teratogen
0,627  0,013  Radioprotector
0,598  0,004  5 Hydroxytryptamine 7 antagonist
0,594  0,023  Embryotoxic
0,580  0,013  UGT1A9 substrate
0,573  0,009  Calcium channel L-type activator
0,541  0,004  Antiparkinsonian, tremor relieving
0,533  0,005  Skeletal muscle relaxant
0,536  0,010  Anticonvulsant
0,516  0,004  Alpha 2b adrenoreceptor antagonist
0,520  0,011  UDP-glucuronosyltransferase substrate
0,571  0,062  Antiinflammatory
0,517  0,007  P-glycoprotein inhibitor
0,514  0,007  Antiulcerative
0,503  0,004  5 Hydroxytryptamine uptake inhibitor
0,491  0,003  Adrenaline uptake inhibitor
0,501  0,023  CYP2C19 inhibitor
0,505  0,032  Antipruritic, allergic
0,487  0,015  Eye irritation, high
0,487  0,016  Cardiodepressant
0,499  0,029  Histamine release inhibitor
0,471  0,004  Nav1.3 sodium channel blocker
0,472  0,005  Nav1.2 sodium channel blocker
0,475  0,029  Antipsychotic
0,484  0,041  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,445  0,012  Anesthetic general
0,478  0,046  Antiparkinsonian
0,426  0,004  Alpha 2a adrenoreceptor antagonist
0,424  0,003  5 Hydroxytryptamine 5A antagonist
0,406  0,004  Alpha 2c adrenoreceptor antagonist
0,411  0,014  UGT1A4 substrate
0,401  0,003  5 Hydroxytryptamine 5 antagonist
0,400  0,005  Alpha 2 adrenoreceptor antagonist
0,422  0,028  Mutagenic
0,441  0,055  Transcription factor NF kappa B inhibitor
0,431  0,046  Vasodilator, peripheral
0,401  0,021  Ca2+/calmodulin-dependent kinase II alpha inhibitor
0,372  0,003  Sphingomyelinase inhibitor
0,411  0,042  FMO1 substrate
0,365  0,008  Acetylcholine M1 receptor antagonist
0,371  0,021  Abortion inducer
0,382  0,034  Carcinogenic
0,354  0,009  Anesthetic local
0,346  0,005  Antieczematic
0,344  0,008  Antihistaminic
0,361  0,028  Sigma receptor agonist
0,338  0,008  Histamine antagonist
0,358  0,028  Flavin-containing monooxygenase substrate
0,374  0,050  Respiratory analeptic
0,420  0,099  Caspase 9 stimulant
0,387  0,067  GABA C receptor rho-3 antagonist
0,333  0,014  5 Hydroxytryptamine 2 antagonist
0,358  0,045  Calcium channel activator
0,371  0,059  Antiallergic
0,324  0,013  5 Hydroxytryptamine 2B antagonist
0,328  0,018  Anesthetic
0,314  0,006  Antiemetic
0,324  0,018  Antialcoholic
0,310  0,006  Histamine H1 receptor antagonist
0,317  0,013  Cholinergic antagonist
0,315  0,012  Adenylate cyclase inhibitor
0,311  0,013  Antiadrenergic
0,315  0,017  Attention deficit/hyperactivity disorder treatment
0,307  0,013  Antipruritic
0,349  0,056  Vasodilator, coronary
0,313  0,022  5 Hydroxytryptamine 1E antagonist
0,293  0,006  Phobic disorders treatment
0,290  0,006  5 Hydroxytryptamine 3E antagonist
0,302  0,022  Antipruritic, non-allergic
0,295  0,014  Acetylcholine antagonist
0,345  0,066  Antithrombotic
0,368  0,090  TNF expression inhibitor
0,293  0,016  Alpha adrenoreceptor antagonist
0,323  0,050  FMO3 substrate
0,331  0,059  Analeptic
0,297  0,025  Peptidyltransferase inhibitor
0,285  0,014  Adrenaline antagonist
0,280  0,010  5 Hydroxytryptamine 2C antagonist
0,316  0,049  Radiosensitizer
0,289  0,023  UGT1A3 substrate
0,350  0,086  GST A substrate
0,265  0,005  5 Hydroxytryptamine 1D antagonist
0,274  0,016  Antidiarrheal
0,270  0,012  Acetylcholine muscarinic antagonist
0,261  0,004  Histamine H2 receptor antagonist
0,282  0,026  Antieczematic atopic
0,267  0,013  5 Hydroxytryptamine 2A antagonist
0,268  0,015  Aldehyde oxidase substrate
0,286  0,036  UGT1A1 substrate
0,259  0,009  Alpha 1b adrenoreceptor antagonist
0,287  0,040  Tyrosine 3 hydroxylase inhibitor
0,270  0,026  Skin irritative effect
0,249  0,006  5 Hydroxytryptamine 1B antagonist
0,265  0,023  5 Hydroxytryptamine antagonist
0,279  0,038  Antihypotensive
0,244  0,008  Dopamine D1 antagonist
0,290  0,055  Cardiovascular analeptic
0,247  0,014  ATPase inhibitor
0,294  0,064  UGT2B4 substrate
0,287  0,058  GST M1-1 substrate
0,287  0,062  Chemoprotective
0,280  0,060  Platelet antagonist
0,231  0,012  Nav1.4 sodium channel blocker
0,224  0,006  Adenylate cyclase stimulant
0,221  0,005  Acetylcholine M4 receptor antagonist
0,255  0,040  Antimigraine
0,220  0,008  Alpha 1d adrenoreceptor antagonist
0,336  0,128  Antiarthritic
0,287  0,079  CTGF expression inhibitor
0,239  0,033  RET inhibitor
0,264  0,061  HERG channel blocker
0,207  0,008  Posttraumatic stress disorder treatment
0,243  0,046  Sleep disorders treatment
0,261  0,067  Gastrin inhibitor
0,237  0,044  CYP2B6 inhibitor
0,208  0,016  5 Hydroxytryptamine 1 antagonist
0,205  0,013  Antineoplastic, alkylator
0,256  0,064  Potassium channel (Voltage-sensitive) blocker
0,200  0,008  Beta tubulin antagonist
0,196  0,006  Toll-Like receptor 3 antagonist
0,258  0,069  Urologic disorders treatment
0,206  0,020  Alpha 1 adrenoreceptor antagonist
0,259  0,075  DNA damaging
0,187  0,005  Acetylcholine M5 receptor antagonist
0,255  0,076  5 Hydroxytryptamine uptake stimulant
0,209  0,031  Acetylcholinesterase inhibitor
0,195  0,017  Alpha 1a adrenoreceptor antagonist
0,188  0,012  Nitric-oxide synthase inhibitor
0,261  0,087  Insulysin inhibitor
0,190  0,016  Mediator release inhibitor
0,213  0,041  Cholinergic
0,216  0,045  Antianorexic
0,185  0,015  Nav1.5 sodium channel blocker
0,199  0,029  GABA C receptor rho-2 antagonist
0,276  0,107  Antineoplastic (small cell lung cancer)
0,177  0,008  Acetylcholine M3 receptor antagonist
0,185  0,019  Sulfotransferase substrate
0,227  0,064  Platelet aggregation inhibitor
0,171  0,008  Dopamine uptake inhibitor
0,218  0,059  Pneumotoxic
0,319  0,159  Apoptosis agonist
0,242  0,085  Interleukin agonist
0,226  0,072  Antineoplastic (glioblastoma multiforme)
0,158  0,005  Beta 3 adrenoreceptor antagonist
0,162  0,010  Acetylcholine M2 receptor antagonist
0,161  0,009  Glutamate (mGluR7) agonist
0,165  0,016  GABA C receptor rho-1 antagonist
0,236  0,088  Aldehyde oxidase inhibitor
0,187  0,043  Carcinogenic, group 1
0,197  0,054  Urinary incontinence treatment
0,243  0,103  Antiepileptic
0,256  0,116  Antihypertensive
0,161  0,022  Gastric antisecretory
0,180  0,041  Sodium channel blocker
0,162  0,025  Papain-like protease (SARS coronavirus) inhibitor
0,171  0,034  Hearing loss treatment
0,161  0,025  GABA C receptor antagonist
0,185  0,050  UGT2B10 substrate
0,179  0,044  Cytokine production inhibitor
0,187  0,053  Acaricide
0,149  0,015  Dopamine D3 antagonist
0,157  0,024  Dopamine antagonist
0,152  0,020  5 Hydroxytryptamine 1A antagonist
0,145  0,016  Dopamine agonist
0,144  0,016  Histamine N-methyltransferase inhibitor
0,174  0,047  Raynaud's phenomenon treatment
0,163  0,036  Antismoking
0,168  0,043  Sodium channel (voltage-gated) blocker
0,163  0,041  Nav1.6 sodium channel blocker
0,145  0,024  Prolactin inhibitor
0,153  0,033  GABA C receptor agonist
0,170  0,051  Toll-Like receptor 9 antagonist
0,165  0,048  Calcium channel blocker
0,217  0,100  Superoxide dismutase inhibitor
0,165  0,051  SULT1A3 substrate
0,163  0,049  Movement disorders treatment
0,148  0,035  Shock treatment
0,208  0,095  Antiprotozoal (Leishmania)
0,182  0,069  Lipocortins synthesis antagonist
0,209  0,097  Antiviral (West Nile virus)
0,208  0,096  NOS2 expression inhibitor
0,159  0,048  Cocaine dependence treatment
0,121  0,010  5 Hydroxytryptamine 6 antagonist
0,165  0,055  Genotoxic
0,124  0,015  Calcium channel L-type blocker
0,178  0,070  Antirickettsial
0,146  0,038  Excitatory amino acid transporter EAAC1 inhibitor
0,237  0,129  CYP3A4 inhibitor
0,170  0,062  Neuropathy treatment
0,116  0,011  Beta adrenoreceptor antagonist
0,143  0,040  Contraceptive female
0,111  0,009  Dopamine transporter inhibitor
0,201  0,099  Antineoplastic (glioma)
0,110  0,008  Beta 1 adrenoreceptor antagonist
0,206  0,105  Antineoplastic (renal cancer)
0,105  0,005  5 Hydroxytryptamine 3B antagonist
0,188  0,089  Neurotrophic factor enhancer
0,148  0,049  Antihelmintic (Trematoda)
0,107  0,010  Antidote, organophosphates
0,166  0,069  Neurotensin receptor agonist
0,209  0,113  Proliferative diseases treatment
0,101  0,006  5 Hydroxytryptamine 4 antagonist
0,162  0,070  Uterine stimulant
0,199  0,107  Antineoplastic (non-small cell lung cancer)
0,098  0,008  Beta 2 adrenoreceptor antagonist
0,116  0,028  Dopamine D2 antagonist
0,092  0,005  GABA transporter 2 inhibitor
0,115  0,029  Restless leg syndrome treatment
0,187  0,101  Potassium channel blocker
0,111  0,026  Antiprotozoal activity enhancer
0,090  0,005  Adenylate cyclase 1 inhibitor
0,125  0,041  Acetylcholine release stimulant
0,147  0,064  Histone deacetylase SIRT1 inhibitor
0,222  0,140  AR expression inhibitor
0,090  0,009  5 Hydroxytryptamine 1B agonist
0,111  0,029  Glutamate release inhibitor
0,168  0,087  LDLR expression enhancer
0,155  0,073  Antimutagenic
0,111  0,031  CYP2A6 inhibitor
0,102  0,022  Protein kinase C alpha inhibitor
0,136  0,056  Vanilloid 1 agonist
0,116  0,037  Alcohol dehydrogenase inhibitor
0,124  0,045  Nav1.1 sodium channel blocker
0,217  0,139  Bone diseases treatment
0,147  0,070  Protein kinase stimulant
0,107  0,031  Inducible nitric-oxide synthase inhibitor
0,079  0,004  Histamine H1 receptor agonist
0,104  0,029  Glycine receptor antagonist
0,169  0,096  Ca2+/calmodulin-dependent protein kinase inhibitor
0,142  0,069  Heat shock protein 70 antagonist
0,090  0,018  Alpha 2 adrenoreceptor agonist
0,079  0,008  Histamine H2 receptor agonist
0,092  0,020  Phospholipase D inhibitor
0,082  0,012  Opioid kappa receptor agonist
0,097  0,028  Estrogen-related receptor beta agonist
0,131  0,062  Cathepsin H inhibitor
0,121  0,055  Calcium channel (voltage-sensitive) blocker
0,079  0,013  Nicotinic alpha3beta2 receptor antagonist
0,133  0,068  Tubulin antagonist
0,069  0,004  Melatonin receptor 1A agonist
0,137  0,072  Neurotrophic factor
0,083  0,021  SULT2A1 substrate
0,069  0,007  Alpha 1d adrenoreceptor agonist
0,112  0,051  Anticataract
0,118  0,056  Glutathione S-transferase substrate
0,096  0,035  Nicotinic alpha4beta2 receptor antagonist
0,086  0,027  S-adenosyl-L-methionine decarboxylase inhibitor
0,083  0,023  5 Hydroxytryptamine 3 antagonist
0,114  0,055  NAT2 substrate
0,125  0,066  Coagulant
0,148  0,089  UGT2B7 substrate
0,138  0,080  Ca2+-transporting ATPase inhibitor
0,115  0,057  Mental retardation treatment
0,102  0,045  Carcinogenic, group 2A
0,101  0,043  Ornithine decarboxylase inhibitor
0,086  0,030  Dopamine D4 antagonist
0,080  0,024  Androgen agonist
0,108  0,053  Anabolic
0,071  0,017  Potassium channel (Inward rectifier) blocker
0,175  0,120  UGT1A6 substrate
0,109  0,055  GST T1-1 substrate
0,126  0,072  Alpha-N-acetylglucosaminidase inhibitor
0,136  0,083  Corneal wound healing stimulator
0,099  0,046  Antidote, mercury
0,190  0,138  DNA synthesis inhibitor
0,094  0,043  Acetylcholine nicotinic antagonist
0,066  0,016  Squalene epoxidase inhibitor
0,089  0,038  Analgesic, opioid
0,063  0,013  Kinesin-like protein 1 inhibitor
0,063  0,013  Kinesin antagonist
0,053  0,005  Amino-acid-polyamine-organocation (APC) transporter antagonist
0,189  0,140  Neuropeptide Y2 antagonist
0,135  0,087  Antidote
0,095  0,047  Tocolytic
0,079  0,032  Female sexual dysfunction treatment
0,068  0,021  5 Hydroxytryptamine 7 agonist
0,059  0,012  Dopamine D5 agonist
0,103  0,056  Creatine kinase inhibitor
0,120  0,074  Antiseptic
0,159  0,113  Antimitotic
0,064  0,018  Immunoglobulin Fc receptor antagonist
0,067  0,021  Histamine agonist
0,067  0,021  5 Hydroxytryptamine 2 agonist
0,167  0,122  VEGF expression inhibitor
0,113  0,068  Estrogen antagonist
0,082  0,037  Vanilloid 4 agonist
0,115  0,071  Antineoplastic antimetabolite
0,075  0,032  5 Hydroxytryptamine 2A agonist
0,128  0,085  Hair growth stimulant
0,169  0,126  Antineoplastic (lymphocytic leukemia)
0,181  0,139  Antineoplastic (ovarian cancer)
0,115  0,073  Alkylator
0,064  0,023  Thromboxane synthase inhibitor
0,079  0,038  Alpha adrenoreceptor agonist
0,073  0,033  NMDA receptor agonist
0,116  0,077  MAO inhibitor
0,108  0,069  SULT1A1 substrate
0,103  0,064  Antiviral (Poxvirus)
0,112  0,073  Antiprotozoal (Babesia)
0,099  0,060  UGT2B11 substrate
0,150  0,112  Succinate dehydrogenase inhibitor
0,107  0,068  5 Hydroxytryptamine 3A agonist
0,077  0,039  Neuronal nicotinic receptor antagonist
0,169  0,132  Vasodilator
0,076  0,041  Phenylalanine 4-hydroxylase inhibitor
0,091  0,056  Antiviral (Hepatitis A)
0,061  0,027  Epithelial sodium channel blocker
0,199  0,165  Cholesterol antagonist
0,067  0,034  Carbonic anhydrase stimulant
0,110  0,077  Calcium channel N-type blocker
0,077  0,043  Potassium channel (Tandem pore domain) blocker
0,214  0,181  Ulceration
0,097  0,064  Butyrylcholinesterase inhibitor
0,045  0,013  Melatonin 2 agonist
0,100  0,068  Factor V inhibitor
0,066  0,034  Histone deacetylase SIRT3 inhibitor
0,046  0,014  Delayed rectifier potassium channel blocker
0,110  0,078  Carcinogenic, group 3
0,068  0,036  Antiviral (Parainfluenza)
0,107  0,076  Photosensitizer
0,060  0,028  Thromboxane A2 antagonist
0,084  0,053  Adrenaline agonist
0,047  0,018  Histone deacetylase 9 inhibitor
0,147  0,118  Non-steroidal antiinflammatory agent
0,042  0,013  Melatonin agonist
0,137  0,108  Muscular dystrophy treatment
0,149  0,121  I kappa B kinase epsilon inhibitor
0,071  0,043  Sphingosine 1-phosphate receptor 4 agonist
0,038  0,010  Dopamine autoreceptor agonist
0,139  0,111  Sensitization
0,147  0,120  Toxic, respiratory center
0,107  0,081  Menstruation disorders treatment
0,072  0,046  Bulimia treatment
0,077  0,051  GABA aminotransferase inhibitor
0,059  0,033  Thromboxane antagonist
0,036  0,011  Nicotinic alpha4beta2 receptor agonist
0,030  0,005  GABA transporter inhibitor
0,073  0,049  Aminopeptidase I inhibitor
0,081  0,057  Sleep apnea treatment
0,133  0,109  Melanin inhibitor
0,049  0,026  Dopamine D5 antagonist
0,205  0,182  Ca(v)3.3 blocker
0,069  0,047  Premenstrual syndrome treatment
0,039  0,016  Melatonin 1 agonist
0,048  0,026  Baculoviral IAP repeat-containing protein inhibitor
0,055  0,033  NMDA 2A receptor antagonist
0,057  0,035  Acyl-CoA dehydrogenase inhibitor
0,096  0,075  Ferrochelatase inhibitor
0,047  0,027  Geranyltranstransferase inhibitor
0,093  0,073  Chronic obstructive bronchitis treatment
0,114  0,095  Toll-Like receptor antagonist
0,051  0,032  Alpha 1b adrenoreceptor agonist
0,090  0,071  Lanosterol 14 alpha demethylase inhibitor
0,105  0,086  Interleukin 8 antagonist
0,057  0,039  Postcoital contraceptive
0,051  0,034  Sigma receptor antagonist
0,082  0,064  Myeloperoxidase inhibitor
0,103  0,086  Microtubule formation inhibitor
0,081  0,064  Ca(v)2.2 blocker
0,080  0,064  Calcium antagonist
0,097  0,081  GABA receptor agonist
0,111  0,096  Antiviral (Papilloma)
0,045  0,030  Histamine H3 receptor antagonist
0,125  0,110  Neuropeptide Y1 antagonist
0,037  0,022  Opioid delta receptor agonist
0,045  0,031  Potassium channel small-conductance Ca-activated blocker
0,020  0,007  NMDA receptor phencyclidine site antagonist
0,022  0,009  Alpha 2c adrenoreceptor agonist
0,070  0,057  NAT1 substrate
0,079  0,067  CC chemokine 5 receptor agonist
0,018  0,006  GABA transporter 1 inhibitor
0,096  0,084  Protein kinase C gamma inhibitor
0,018  0,006  Melatonin receptor 1A antagonist
0,056  0,045  CXC chemokine 4 receptor antagonist
0,123  0,113  Cyclin-dependent kinase 8 inhibitor
0,106  0,095  Toll-Like receptor 2 antagonist
0,060  0,050  Hyperparathyroidism treatment
0,040  0,030  Histone deacetylase 8 inhibitor
0,037  0,027  Diamine oxidase inhibitor
0,031  0,021  Endothelial nitric-oxide synthase inhibitor
0,094  0,084  Rhinitis treatment
0,086  0,076  Aminopeptidase B inhibitor
0,059  0,049  Heme oxygenase stimulant
0,075  0,066  Opioid kappa receptor antagonist
0,074  0,065  Acetylcholine nicotinic agonist
0,026  0,017  Vanilloid 2 agonist
0,028  0,019  Melatonin antagonist
0,051  0,042  Postmenopausal disorders treatment
0,032  0,023  Estrogen-related receptor beta antagonist
0,034  0,025  Retinoid X alpha receptor agonist
0,126  0,118  Arachidonic acid antagonist
0,019  0,010  Alpha 2a adrenoreceptor agonist
0,019  0,010  KiSS-1 receptor antagonist
0,020  0,012  Histamine H4 receptor agonist
0,017  0,009  Thromboxane A2 agonist
0,090  0,083  Estrogen receptor beta antagonist
0,037  0,030  Membrane dipeptidase inhibitor
0,028  0,021  5 Hydroxytryptamine 1D agonist
0,138  0,132  Phospholipase C inhibitor
0,031  0,024  GABA transporter 3 inhibitor
0,028  0,022  AMPA 3 receptor antagonist
0,031  0,025  Sirtuin 2 inhibitor
0,089  0,083  Falcipain 3 inhibitor
0,045  0,040  Histamine H4 receptor antagonist
0,047  0,043  Opioid agonist
0,076  0,072  Acetylcholine agonist
0,026  0,023  Thrombin receptor antagonist
0,063  0,061  Exportin-1 inhibitor
0,027  0,024  Estrogen-related receptor gamma antagonist
0,039  0,037  Nerve growth factor antagonist
0,026  0,023  Baculoviral IAP repeat-containing protein 4 inhibitor
0,023  0,021  Glutamate (mGluR1) agonist
0,005  0,004  P2 nucleoside transporter inhibitor
0,037  0,036  Phenylethanolamine N methyltransferase inhibitor
0,058  0,057  Histone deacetylase inhibitor
0,014  0,013  Prostacyclin agonist
0,017  0,016  Melatonin 1 antagonist
0,154  0,153  Acute neurologic disorders treatment
0,161  0,161  Antineoplastic (melanoma)

